Liming Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liming Ge has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Changdao Mu
Sichuan University
31 shared publications- Defu Li
Sichuan University
29 shared publications Xinying Li
Southwest Minzu University
17 shared publicationsZhilang Xu
Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, People’s Republic of China
16 shared publicationsDefu Li
Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, People’s Republic of China
13 shared publicationsLun Yuan
Department of Pharmaceutics and Bioengineering, School of Chemical Engineering, Sichuan University, No. 24 South Section 1, Yihuan Road, Chengdu 610065, P. R. China
12 shared publications
Latest Publications
- 4 November 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
Microenvironment-Responsive Polyaniline− Gelatin Conductive Hydrogel Promotes Infected Diabetic Wound Healing by Modulating Skin-Resident Cells Behavior
Diabetic wound healing is severely impaired by persistent inflammation, bacterial infection, impaired angiogenesis, and especially disrupted bioelectrical signaling. Conductive hydrogels can help restore local bioelectrical signal transmission and provide an attractive strategy for intractable wound healing by modulating the behaviors of bioelectrically responsive skin-resident cells. Here, we developed a glucose/pH-responsive polyaniline− gelatin conductive hydrogel (HGP@D) based on double dynamic covalent crosslinking of the imine bond and boronic ester bond for promoting the Staphylococcus aureus-infected full-thickness diabetic wound healing. The HGP@D hydrogel had strong mechanical property, great tissue adhesive strength, glucose/pH dual-responsive drug release behavior, alongside robust broad-spectrum antibacterial activity, and potent intracellular antioxidation. The HGP@D hydrogel restored local bioelectrical signaling and created an anti-inflammatory wound microenvironment, thereby modulating the behaviors of skin-resident cells involved in diabetic wound repair, including fibroblast migration, macrophage M2-like polarization, and endothelial angiogenic activity. Mechanistic analyses suggested that the HGP@D hydrogel promoted infected diabetic wound healing through two Ca2+-associated regulatory axes: the Ca2+/CaMKKβ/AMPK/NF-κB axis for inflammatory regulation and the Ca2+/PI3K/Akt/mTOR/HIF-1α/VEGF axis for angiogenesis and tissue reconstruction. Overall, HGP@D provides a promising clinical therapeutic strategy for the advanced healing of diabetic wounds and other non-healing wounds by integrating glucose/pH-responsive microenvironment regulation with bioelectrical modulation.
- 4 November 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
Microenvironment-Responsive Polyaniline− Gelatin Conductive Hydrogel Promotes Infected Diabetic Wound Healing by Modulating Skin-Resident Cells Behavior
Diabetic wound healing is severely impaired by persistent inflammation, bacterial infection, impaired angiogenesis, and especially disrupted bioelectrical signaling. Conductive hydrogels can help restore local bioelectrical signal transmission and provide an attractive strategy for intractable wound healing by modulating the behaviors of bioelectrically responsive skin-resident cells. Here, we developed a glucose/pH-responsive polyaniline− gelatin conductive hydrogel (HGP@D) based on double dynamic covalent crosslinking of the imine bond and boronic ester bond for promoting the Staphylococcus aureus-infected full-thickness diabetic wound healing. The HGP@D hydrogel had strong mechanical property, great tissue adhesive strength, glucose/pH dual-responsive drug release behavior, alongside robust broad-spectrum antibacterial activity, and potent intracellular antioxidation. The HGP@D hydrogel restored local bioelectrical signaling and created an anti-inflammatory wound microenvironment, thereby modulating the behaviors of skin-resident cells involved in diabetic wound repair, including fibroblast migration, macrophage M2-like polarization, and endothelial angiogenic activity. Mechanistic analyses suggested that the HGP@D hydrogel promoted infected diabetic wound healing through two Ca2+-associated regulatory axes: the Ca2+/CaMKKβ/AMPK/NF-κB axis for inflammatory regulation and the Ca2+/PI3K/Akt/mTOR/HIF-1α/VEGF axis for angiogenesis and tissue reconstruction. Overall, HGP@D provides a promising clinical therapeutic strategy for the advanced healing of diabetic wounds and other non-healing wounds by integrating glucose/pH-responsive microenvironment regulation with bioelectrical modulation.
- Open Access
- 1 September 2026
- Published by Springer Nature in Collagen and Leather
- Vol. 8 (1) , 35
Near-infrared light-activated collagen-based hydrogel with oriented microchannel structure promoting fibroblast infiltration and inflammatory resolution
- 1 September 2026
- Published by Springer Nature in Collagen and Leather
- Vol. 8 (1) , 35
Open AccessNear-infrared light-activated collagen-based hydrogel with oriented microchannel structure promoting fibroblast infiltration and inflammatory resolution
- 21 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (17) , 24224-24244
Injectable Double-Cross-Linked Hydrogel Enhanced by Mg/Mn-Based Nanozymes for Photothermal Therapy and Immunomodulation in Periodontal Bone Resorption
The repair of irregular periodontal bone defects remains a formidable clinical challenge due to the complex oral microenvironment, which demands that therapeutic materials integrate early antibacterial and anti-inflammatory effects with sustained osteogenic support. Herein, we present an injectable multifunctional double-cross-linked hydrogel (GGCM) based on gelatin and chondroitin sulfate (CS), incorporating Mg/Mn-based nanozymes (MPM NZs) for photothermal therapy of periodontitis. MPM NZs were first synthesized via chemical deposition of nano-MnO2 onto mesoporous MgO nanoparticles and subsequently incorporated into a dual-cross-linked network formed by glycidyl methacrylate-modified gelatin and oxidized chondroitin sulfate (OCS) through sequential Schiff base and photopolymerization reactions. The resulting GGCM hydrogel exhibited a favorable microporous architecture, robust physicochemical properties, and excellent injectability to fill irregular periodontal pockets. Notably, MPM NZs endowed the hydrogel with potent photothermal antibacterial activity (>95%), superoxide dismutase (SOD)- and catalase (CAT)-mimetic activities for reactive oxygen species (ROS) scavenging, and the sustained release of bioactive Mg2+ and Mn2+ ions for immunomodulation and osteogenesis. Importantly, GGCM enables a time-sequential regenerative therapeutic cascade comprising rapid periodontal pathogen elimination upon NIR irradiation, subsequent anti-inflammatory immunomodulation via M2 macrophage polarization, and continuous osteogenic promotion and alveolar bone resorption reduction. Collectively, this multifunction-integrated MPM NZ-enhanced double-cross-linked hydrogel exhibits promising potential for periodontal bone regeneration, positioning it as a highly attractive photothermal therapeutic strategy for periodontitis and even other complex infectious bone defects.
- 21 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (17) , 24224-24244
Injectable Double-Cross-Linked Hydrogel Enhanced by Mg/Mn-Based Nanozymes for Photothermal Therapy and Immunomodulation in Periodontal Bone Resorption
The repair of irregular periodontal bone defects remains a formidable clinical challenge due to the complex oral microenvironment, which demands that therapeutic materials integrate early antibacterial and anti-inflammatory effects with sustained osteogenic support. Herein, we present an injectable multifunctional double-cross-linked hydrogel (GGCM) based on gelatin and chondroitin sulfate (CS), incorporating Mg/Mn-based nanozymes (MPM NZs) for photothermal therapy of periodontitis. MPM NZs were first synthesized via chemical deposition of nano-MnO2 onto mesoporous MgO nanoparticles and subsequently incorporated into a dual-cross-linked network formed by glycidyl methacrylate-modified gelatin and oxidized chondroitin sulfate (OCS) through sequential Schiff base and photopolymerization reactions. The resulting GGCM hydrogel exhibited a favorable microporous architecture, robust physicochemical properties, and excellent injectability to fill irregular periodontal pockets. Notably, MPM NZs endowed the hydrogel with potent photothermal antibacterial activity (>95%), superoxide dismutase (SOD)- and catalase (CAT)-mimetic activities for reactive oxygen species (ROS) scavenging, and the sustained release of bioactive Mg2+ and Mn2+ ions for immunomodulation and osteogenesis. Importantly, GGCM enables a time-sequential regenerative therapeutic cascade comprising rapid periodontal pathogen elimination upon NIR irradiation, subsequent anti-inflammatory immunomodulation via M2 macrophage polarization, and continuous osteogenic promotion and alveolar bone resorption reduction. Collectively, this multifunction-integrated MPM NZ-enhanced double-cross-linked hydrogel exhibits promising potential for periodontal bone regeneration, positioning it as a highly attractive photothermal therapeutic strategy for periodontitis and even other complex infectious bone defects.
- 9 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 21682-21699
Antibacterial Conductive Polysaccharide-Based Hydrogel Microneedle Patches Accelerate Infected Diabetic Wound Healing through Anti-Inflammatory and Pro-Angiogenesis
Diabetic ulcers (DUs) are a main category of nonhealing chronic wounds that tend to be vulnerable and prone to recurrence, posing a significant clinical challenge for DUs healing. DUs are frequently plagued by bacterial infections, oxidative stress, persistent inflammation, suppressed angiogenesis, and reduced growth factor expression, ultimately leading to persistent barriers to tissue regeneration and even amputation. Herein, we developed a multifunctional polysaccharide-based conductive hydrogel microneedle patch (MN-EP) integrating hyaluronic acid (HA) needle shafts, carboxymethyl chitosan-oxidized HA (CMCS-OHA) hydrogel backing, and oregano essential oil (OEO)-loaded polypyrrole (PPy) nanoparticles (EP NPs). MN-EP exhibited sufficient mechanical strength to penetrate stratum corneum, favorable conductivity matching skin tissue due to EP NPs, broad-spectrum antibacterial activity (nearly 100% against Staphylococcus aureus and Escherichia coli), and potent antioxidant capacity. It was demonstrated that MN-EP can scavenge intracellular reactive oxygen species (ROS), induce macrophage polarization toward the anti-inflammatory M2 phenotype, and promote fibroblast migration. In diabetic rats with infected full-thickness wounds, the electroactive MN-EP effectively eliminated harmful microorganisms at the wound site and modulated the immune microenvironment, thereby accelerating the resolution of inflammation, enhancing collagen deposition, and upregulating angiogenesis markers (CD31, VEGF), which promoted vascular and tissue regeneration and accelerated wound closure (98.28% by day 14). Overall, the multifunctional conductive hydrogel microneedle platform with antibacterial, anti-inflammatory, and pro-angiogenic properties represents a promising strategy for infected chronic diabetic wound healing.
- 9 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 21682-21699
Antibacterial Conductive Polysaccharide-Based Hydrogel Microneedle Patches Accelerate Infected Diabetic Wound Healing through Anti-Inflammatory and Pro-Angiogenesis
Diabetic ulcers (DUs) are a main category of nonhealing chronic wounds that tend to be vulnerable and prone to recurrence, posing a significant clinical challenge for DUs healing. DUs are frequently plagued by bacterial infections, oxidative stress, persistent inflammation, suppressed angiogenesis, and reduced growth factor expression, ultimately leading to persistent barriers to tissue regeneration and even amputation. Herein, we developed a multifunctional polysaccharide-based conductive hydrogel microneedle patch (MN-EP) integrating hyaluronic acid (HA) needle shafts, carboxymethyl chitosan-oxidized HA (CMCS-OHA) hydrogel backing, and oregano essential oil (OEO)-loaded polypyrrole (PPy) nanoparticles (EP NPs). MN-EP exhibited sufficient mechanical strength to penetrate stratum corneum, favorable conductivity matching skin tissue due to EP NPs, broad-spectrum antibacterial activity (nearly 100% against Staphylococcus aureus and Escherichia coli), and potent antioxidant capacity. It was demonstrated that MN-EP can scavenge intracellular reactive oxygen species (ROS), induce macrophage polarization toward the anti-inflammatory M2 phenotype, and promote fibroblast migration. In diabetic rats with infected full-thickness wounds, the electroactive MN-EP effectively eliminated harmful microorganisms at the wound site and modulated the immune microenvironment, thereby accelerating the resolution of inflammation, enhancing collagen deposition, and upregulating angiogenesis markers (CD31, VEGF), which promoted vascular and tissue regeneration and accelerated wound closure (98.28% by day 14). Overall, the multifunctional conductive hydrogel microneedle platform with antibacterial, anti-inflammatory, and pro-angiogenic properties represents a promising strategy for infected chronic diabetic wound healing.
- 5 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (50) , 67626-67640
Decellularized Dermal Barrier Membrane with Enhanced Osteogenic Potential for Bone Defect Regeneration
The ability of collagen-based resorbable barrier membranes to stabilize microenvironments is a current clinical concern for guided bone regeneration (GBR) technology. Decellularized dermal membranes are a research hotspot now, which can retain the natural three-dimensional extracellular matrix (ECM) structure and provide a positive microenvironment for cell adhesion and proliferation, thereby promoting tissue healing and regeneration. However, imperfect decellularization methods often result in weaker performance than collagen membranes in clinical practice (e.g., Bio-Gide membrane). Hence, we propose a composite decellularization technique combining chemical and biological enzymatic methods, supplemented by physical techniques, to obtain a high-performance decellularized dermal membrane for GBR. The prepared decellularized dermal membrane effectively maintained the original 3D microstructure and natural components (collagen and elastin) of the ECM, exhibiting good physical properties and biocompatibility. Decellularized dermal membranes can promote fibroblast adhesion and growth on the surface while effectively preventing fibroblasts from invading the injured site. Moreover, the decellularized dermal membrane showed the potential to induce osteogenesis and inhibit osteoclast formation. In vivo cranial defect experiments demonstrated the superior GBR performance of the decellularized dermal membrane compared to commercial Bio-Gide membrane.
- 5 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (50) , 67626-67640
Decellularized Dermal Barrier Membrane with Enhanced Osteogenic Potential for Bone Defect Regeneration
The ability of collagen-based resorbable barrier membranes to stabilize microenvironments is a current clinical concern for guided bone regeneration (GBR) technology. Decellularized dermal membranes are a research hotspot now, which can retain the natural three-dimensional extracellular matrix (ECM) structure and provide a positive microenvironment for cell adhesion and proliferation, thereby promoting tissue healing and regeneration. However, imperfect decellularization methods often result in weaker performance than collagen membranes in clinical practice (e.g., Bio-Gide membrane). Hence, we propose a composite decellularization technique combining chemical and biological enzymatic methods, supplemented by physical techniques, to obtain a high-performance decellularized dermal membrane for GBR. The prepared decellularized dermal membrane effectively maintained the original 3D microstructure and natural components (collagen and elastin) of the ECM, exhibiting good physical properties and biocompatibility. Decellularized dermal membranes can promote fibroblast adhesion and growth on the surface while effectively preventing fibroblasts from invading the injured site. Moreover, the decellularized dermal membrane showed the potential to induce osteogenesis and inhibit osteoclast formation. In vivo cranial defect experiments demonstrated the superior GBR performance of the decellularized dermal membrane compared to commercial Bio-Gide membrane.
- 8 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Bilayer Heterogeneous Methacrylated Silk Fibroin Scaffold with Antibacterial and Osteoinductive Functions for Treating Infectious Bone Defects
Infectious bone defects (IBDs) pose a significant clinical challenge due to the simultaneous requirements for effective infection control and robust bone regeneration, and guided bone regeneration (GBR) using multifunctional scaffolds offers a promising therapeutic strategy. Herein, we developed a bilayer hydrogel scaffold (DSHM) based on methacrylated silk fibroin (SilMA) integrated with hydroxyapatite (HA) and minocycline hydrochloride (MH) to address these demands. By precisely optimizing the concentrations of SilMA, photoinitiator, HA, and MH, we engineered a bilayer structure featuring a porous HA-loaded layer (PSH, ∼432.1 μm) to enhance mechanical strength and support osteogenic differentiation and a dense MH-loaded layer (DSM, ∼34.6 μm) to act as a barrier against fibrous tissue ingrowth and provide sustained antibacterial effects. The interface-cross-linked DSHM scaffold exhibited a well-defined heterogeneous architecture, improved mechanical properties, tunable degradation, and excellent biocompatibility. Notably, the DSHM demonstrated synergistic multifunctionality, including inhibition of fibroblast infiltration, promotion of bone tissue regeneration, and effective infection control. Overall, the DSHM scaffold presents a robust approach for the localized and targeted treatment of IBDs, with strong potential for clinical translation.
- 8 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Bilayer Heterogeneous Methacrylated Silk Fibroin Scaffold with Antibacterial and Osteoinductive Functions for Treating Infectious Bone Defects
Infectious bone defects (IBDs) pose a significant clinical challenge due to the simultaneous requirements for effective infection control and robust bone regeneration, and guided bone regeneration (GBR) using multifunctional scaffolds offers a promising therapeutic strategy. Herein, we developed a bilayer hydrogel scaffold (DSHM) based on methacrylated silk fibroin (SilMA) integrated with hydroxyapatite (HA) and minocycline hydrochloride (MH) to address these demands. By precisely optimizing the concentrations of SilMA, photoinitiator, HA, and MH, we engineered a bilayer structure featuring a porous HA-loaded layer (PSH, ∼432.1 μm) to enhance mechanical strength and support osteogenic differentiation and a dense MH-loaded layer (DSM, ∼34.6 μm) to act as a barrier against fibrous tissue ingrowth and provide sustained antibacterial effects. The interface-cross-linked DSHM scaffold exhibited a well-defined heterogeneous architecture, improved mechanical properties, tunable degradation, and excellent biocompatibility. Notably, the DSHM demonstrated synergistic multifunctionality, including inhibition of fibroblast infiltration, promotion of bone tissue regeneration, and effective infection control. Overall, the DSHM scaffold presents a robust approach for the localized and targeted treatment of IBDs, with strong potential for clinical translation.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32038-32053
Injectable Polysaccharide-Based Hydrogel with Glucose Responsiveness as an Immunoregulatory Platform for Enhanced Diabetic Wound Healing
Persistent excessive inflammatory response in diabetic wounds caused by the imbalance of the immune microenvironment leads to delayed or nonhealing of the wounds. Timely attenuation of inflammation through immunoregulation is a crucial strategy to accelerate diabetic wound closure. Here, the protocatechuic acid (PCA)- and deferoxamine (DFO)-loaded polysaccharide-based immunoregulatory hydrogel (POCP@D) was developed by the dual-cross-linking strategy of borate ester bonds and imine bonds to promote advanced healing of full-thickness diabetic wounds. The POCP@D hydrogel showed good tissue adhesiveness property, flexibility, mechanical strength, injectability, self-healing, and glucose-responsive drug release properties, besides strong broad-spectrum antibacterial and antioxidant activities. The POCP@D hydrogel acted as an immunoregulatory platform to remold the in vivo immune microenvironment of diabetic wounds by regulating the M2-type macrophage polarization and timely relieving wound inflammation, thus promoting collagen deposition, angiogenesis, and the development of diabetic wounds from the inflammatory stage to the proliferative stage and ultimately achieving high-quality skin tissue regeneration. Overall, our developed immunoregulatory hydrogel held great potential for refractory diabetic wound therapy in clinical settings.
- 22 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32038-32053
Injectable Polysaccharide-Based Hydrogel with Glucose Responsiveness as an Immunoregulatory Platform for Enhanced Diabetic Wound Healing
Persistent excessive inflammatory response in diabetic wounds caused by the imbalance of the immune microenvironment leads to delayed or nonhealing of the wounds. Timely attenuation of inflammation through immunoregulation is a crucial strategy to accelerate diabetic wound closure. Here, the protocatechuic acid (PCA)- and deferoxamine (DFO)-loaded polysaccharide-based immunoregulatory hydrogel (POCP@D) was developed by the dual-cross-linking strategy of borate ester bonds and imine bonds to promote advanced healing of full-thickness diabetic wounds. The POCP@D hydrogel showed good tissue adhesiveness property, flexibility, mechanical strength, injectability, self-healing, and glucose-responsive drug release properties, besides strong broad-spectrum antibacterial and antioxidant activities. The POCP@D hydrogel acted as an immunoregulatory platform to remold the in vivo immune microenvironment of diabetic wounds by regulating the M2-type macrophage polarization and timely relieving wound inflammation, thus promoting collagen deposition, angiogenesis, and the development of diabetic wounds from the inflammatory stage to the proliferative stage and ultimately achieving high-quality skin tissue regeneration. Overall, our developed immunoregulatory hydrogel held great potential for refractory diabetic wound therapy in clinical settings.
- Top Cited PapersOpen Access
- 8 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Immunomodulatory multifunctional janus collagen-based membrane for advanced bone regeneration
Guided bone regeneration (GBR) is a standard therapy for treating bone defects, with collagen-based barrier membranes widely used clinically. However, these membranes face challenges like poor mechanical properties, early bacterial invasion and immunomodulation deficiency, potentially risking GBR failure. Orchestrating macrophage activation and controlling their M1 or M2 polarization are effective strategies for bone repair. Here, we present a Janus collagen-based barrier membrane with immunomodulation. The porous layer promotes direct osteogenic differentiation and inward growth of osteoblasts. The dense layer prevents invasion of soft tissue into bone defects and protects bone defects from bacterial infection. The membrane also enhances rat bone marrow-derived mesenchymal stem cell infiltration, proliferation, and osteogenic differentiation by regulating the immune microenvironment, demonstrating superior bone regeneration compared to the commercial Bio-Gide® membrane. Overall, the Janus collagen-based membrane reduces tissue inflammation and fosters an osteoimmune environment conducive to new bone formation, offering effective material design for advanced GBR technology.
- 8 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Top Cited PapersOpen AccessImmunomodulatory multifunctional janus collagen-based membrane for advanced bone regeneration
Guided bone regeneration (GBR) is a standard therapy for treating bone defects, with collagen-based barrier membranes widely used clinically. However, these membranes face challenges like poor mechanical properties, early bacterial invasion and immunomodulation deficiency, potentially risking GBR failure. Orchestrating macrophage activation and controlling their M1 or M2 polarization are effective strategies for bone repair. Here, we present a Janus collagen-based barrier membrane with immunomodulation. The porous layer promotes direct osteogenic differentiation and inward growth of osteoblasts. The dense layer prevents invasion of soft tissue into bone defects and protects bone defects from bacterial infection. The membrane also enhances rat bone marrow-derived mesenchymal stem cell infiltration, proliferation, and osteogenic differentiation by regulating the immune microenvironment, demonstrating superior bone regeneration compared to the commercial Bio-Gide® membrane. Overall, the Janus collagen-based membrane reduces tissue inflammation and fosters an osteoimmune environment conducive to new bone formation, offering effective material design for advanced GBR technology.
- Open Access
- 3 January 2025
- Published by Springer Nature in Collagen and Leather
- Vol. 7 (1) , 1-18
Development of cinnamon essential oil-loaded Pickering emulsions stabilized by chitosan/gelatin nanoparticles with enhanced antibacterial and antibiofilm actives
Bacterial biofilm infection is a complicated and important global problem. Non-toxic biomass-based Pickering emulsions as an essential oil delivery system are a potentially effective means in biofilm treatment. Herein, the chitosan/gelatin complex nanoparticles (CGNPs) stabilized Pickering (CGP) emulsion loaded with cinnamon essential oil (CEO) was developed to inhibit and remove bacterial biofilms. CGNPs were initially successfully prepared with a particle size of 253.7 nm. Subsequently, CGP emulsions were prepared using CGNPs as the emulsifier and CEO as the oil phase, with the aqueous phase pH value of 5.5 and ionic strength of 50 mM. Amino groups of CGNPs were crosslinked with the aldehyde group of CEO via Schiff base reaction at the oil–water interface to form a denser core–shell structure, thus improving the stability of Pickering emulsion. The CGP emulsions exhibit controlled and long-term sustained release properties in essential oil delivery, with 89.8%, 81.0%, and 62.2% CEO release within 168 h for CGP-0.1, CGP-0.2, and CGP-0.3, respectively. Moreover, CGP emulsions have stronger antioxidant activities (nearly 100%), broad-spectrum antibacterial activities (> 90%), enhanced penetration and removal capabilities against preformed biofilms than single CEO or CGNPs, as well as its better biocompatibility than conventional surfactant-stabilized emulsions. Hence, CEO-delivered CGP emulsion could serve as a potential strategy against biofilm infections and bacterial resistance. Graphical abstract
- 3 January 2025
- Published by Springer Nature in Collagen and Leather
- Vol. 7 (1) , 1-18
Open AccessDevelopment of cinnamon essential oil-loaded Pickering emulsions stabilized by chitosan/gelatin nanoparticles with enhanced antibacterial and antibiofilm actives
Bacterial biofilm infection is a complicated and important global problem. Non-toxic biomass-based Pickering emulsions as an essential oil delivery system are a potentially effective means in biofilm treatment. Herein, the chitosan/gelatin complex nanoparticles (CGNPs) stabilized Pickering (CGP) emulsion loaded with cinnamon essential oil (CEO) was developed to inhibit and remove bacterial biofilms. CGNPs were initially successfully prepared with a particle size of 253.7 nm. Subsequently, CGP emulsions were prepared using CGNPs as the emulsifier and CEO as the oil phase, with the aqueous phase pH value of 5.5 and ionic strength of 50 mM. Amino groups of CGNPs were crosslinked with the aldehyde group of CEO via Schiff base reaction at the oil–water interface to form a denser core–shell structure, thus improving the stability of Pickering emulsion. The CGP emulsions exhibit controlled and long-term sustained release properties in essential oil delivery, with 89.8%, 81.0%, and 62.2% CEO release within 168 h for CGP-0.1, CGP-0.2, and CGP-0.3, respectively. Moreover, CGP emulsions have stronger antioxidant activities (nearly 100%), broad-spectrum antibacterial activities (> 90%), enhanced penetration and removal capabilities against preformed biofilms than single CEO or CGNPs, as well as its better biocompatibility than conventional surfactant-stabilized emulsions. Hence, CEO-delivered CGP emulsion could serve as a potential strategy against biofilm infections and bacterial resistance. Graphical abstract
- Open Access
- 19 September 2024
- Published by Springer Nature in Research Square
Immunomodulatory Multifunctional Janus Collagen-based Membrane for Advanced Bone Regeneration
Guided bone regeneration (GBR) is a standard therapy for treating bone defects, with collagen-based barrier membranes widely used clinically. However, these membranes face challenges like early bacterial invasion, risking GBR failure. Effective strategies include orchestrating macrophage activation and controlling their M1 or M2 polarization during bone repair. We present a novel Janus collagen-based barrier membrane with immunomodulatory function. The porous layer promotes direct osteogenic differentiation and inward growth of osteoblasts. The dense layer prevents invasion of soft tissue into bone defects and protects bone defects from bacterial infection. The membrane also enhances rat bone marrow-derived mesenchymal stem cells (rBMSCs) infiltration, proliferation, and osteogenic differentiation by regulating the immune microenvironment. Cranial defect experiments show superior bone regeneration compared to the commercially available Bio-Gide® collagen membrane. Overall, the Janus collagen-based membrane reduces tissue inflammation and fosters an osteoimmune environment conducive to new bone formation, offering innovative material design for advanced GBR technology.
- 19 September 2024
- Published by Springer Nature in Research Square
Open AccessImmunomodulatory Multifunctional Janus Collagen-based Membrane for Advanced Bone Regeneration
Guided bone regeneration (GBR) is a standard therapy for treating bone defects, with collagen-based barrier membranes widely used clinically. However, these membranes face challenges like early bacterial invasion, risking GBR failure. Effective strategies include orchestrating macrophage activation and controlling their M1 or M2 polarization during bone repair. We present a novel Janus collagen-based barrier membrane with immunomodulatory function. The porous layer promotes direct osteogenic differentiation and inward growth of osteoblasts. The dense layer prevents invasion of soft tissue into bone defects and protects bone defects from bacterial infection. The membrane also enhances rat bone marrow-derived mesenchymal stem cells (rBMSCs) infiltration, proliferation, and osteogenic differentiation by regulating the immune microenvironment. Cranial defect experiments show superior bone regeneration compared to the commercially available Bio-Gide® collagen membrane. Overall, the Janus collagen-based membrane reduces tissue inflammation and fosters an osteoimmune environment conducive to new bone formation, offering innovative material design for advanced GBR technology.